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Ferid Murad, MD, PhD at 80: A Legacy of Science, Medicine, and Mentorship
Scott A. Waldman, MD, PhD, FCP, FAHA
Department of Pharmacology and Experimental Therapeutics
Sidney Kimmel Medical College
Thomas Jefferson University
1020 Locust Street, 368 JAH
Philadelphia, PA 19107
and
Prof. Atta-Ur-Rahman, FRS

for their discoveries concerning nitric oxide as a signaling molecule in the cardiovascular system
The Nobel Prize in Physiology or Medicine 1998, The Nobel Foundation
It is hard to believe that it is has been nearly twenty years since the Nobel Prize was awarded
for the discovery of nitric oxide to Robert Furchgott, Louis Ignarro, and Ferid Murad. This, and
the many other awards that these investigators received over the years, recognized the
paradigm-changing importance of their discovery that a gas like nitric oxide could function as a
hormone and mediate signaling that was essential to the physiology and pathophysiology in the
cardiovascular, and virtually all other biological, systems. Individually, they contributed pieces
to the puzzle that ultimately brought these novel molecular insights into specific relief. Dr.
Furchgott was the first to recognize the generation by the endothelium of a signaling molecule
that relaxed vascular smooth muscle, termed endothelium-derived relaxing factor. Dr.
Ignarro’s work, in parallel with Dr. Furchgott, revealed that EDRF was actually nitric oxide, the
active agent which produced smooth muscle relaxation. In a separate series of studies, Dr.
Murad revealed that nitrovasodilators exerted their predominant pharmacologic effect on
blood vessel relaxation because they served as a source for nitric oxide generation. Moreover,
he demonstrated that the primary biological receptor for nitric oxide was cytosolic, or soluble,
guanylate cyclase which regulated vascular smooth muscle contractility through the enzymatic
conversion of GTP to the second messenger cyclic GMP.
The revelation in the 1980’s that nitric oxide was a hormone that signaled, at least in part,
through guanylate cyclase and cGMP, was paradigm-shifting and established a field which has
grown exponentially over the ensuing years. One “marker” of the impact that these seminal
discoveries had is the number of publications they stimulated. Indeed, before these
discoveries, there were only a few hundred papers in the world’s literature on the biology of
nitric oxide. However, in the 30 years after these discoveries were revealed, there have been
nearly 150,000 papers that focus on nitric oxide biology and medicine. In that context, these
discoveries became the foundation for dissecting the molecular mechanisms regulating the
natural production of nitric oxide, through the family of nitric oxide synthases. Indeed, the
regulation of this synthesis and downstream nitric oxide signaling was identified as a key step in
the physiology of the cardiovascular, nervous, reproductive, musculoskeletal, and
immunological systems, to name a few. Further, they nucleated studies that defined the major
mechanisms of nitric oxide signaling beyond guanylate cyclase and cyclic GMP, including the
post-translational modification of proteins by nitric oxide and its reactive derivatives, like
peroxynitrite. In turn, these insights offered novel perspectives on the pathophysiology
contributing to a host of disorders including, but not limited to, vascular insufficiency
syndromes, inflammatory diseases, pulmonary disease, psychiatric disorders, and cancer.
Moreover, these discoveries identified essential components of the nitric oxide signaling
cascade as targets for novel therapeutic approaches to disease management, with active
pharmacotherapies available for cardiovascular disease, impotence, and pulmonary diseases, to
name a few.
Discovery consists of seeing what everybody has seen and thinking what nobody has thought
Albert Szent-Gyorgi

As he turns 80 this year, Dr. Murad can look back on a rich career filled with extraordinarily
impactful molecular discovery and translation of those insights into novel therapeutic
paradigms for individual patients and populations. His gift was to see something that everyone
else had seen, the activity of nitrovasodilators, and then to doggedly pursue the underlying
biology to define previously unknown molecular mechanisms which proved to be paradigm
shifting and field-opening. It is in the context of those discoveries, and the occasion of this
landmark birthday, that we curated this issue to highlight recent work in the field which he was
instrumental in creating. In that context, the review by Sorokin (1) highlights new insights into
the reciprocal interplay between nitric oxide and prostaglandin synthesis that appears to
underlie normal physiology, and which becomes dysfunctional in the pathophysiology of a
variety of systems, for example arthritides, tissue regeneration, and diabetic retinopathies.
Zhao (2) highlights bioengineering studies in which nitric oxide-generating compounds are
fabricated into structures and devices that can be applied to stably administer this hormone to
improve vascular function, speed wound healing, or generate nitric oxide levels locally that are
cytotoxic to tumors. Benhar (3), Cippitelli (4), and Kumar (5) focus on the role of nitric oxide in
processes underlying tumorigenesis in a variety of systems. Indeed, they underscore the
concept that the role of nitric oxide in inducing, or opposing, tumorigenesis depends on context
(which cells make it, which receive it) and concentration. The concept of nitric oxide in brain
function is examined in the review by Phillipu (6), who explores the role of this agent in
regulating synaptic transmission. This theme is advanced by Koseling (7), who highlights the
differential roles of the isoforms of soluble guanylate cyclase in mediating pre- and postsynaptic transmission in brain. In addition to normal physiology, the role of nitric oxide in
pathophysiology in the central nervous system is underscored by Jimenez-Jimenez (8), who
explores the role of dysfunctional nitric oxide signalling in the etiology of neurodegenerative
diseases like Parkinson’s disease. Similarly, the role of abnormal nitric oxide signaling in
mechanisms contributing to psychoses is examined by both Hallak (9) and Pitsikas (10).
Moreover, the role of abnormal nitric oxide signaling in mechanisms underlying neruoinflammation in the context of HIV infection is reviewed by Persichini (11). Beyond the central
nervous system, the role of nitric oxide signaling in the peripheral nervous system mediating
nitrergic transmission in the GI tract which facilitates GI motility is explored by Friebe (12). In
that context, this review underscores the potential role of abnormal nitric oxide signaling in
mediating disorders of GI motility. Nitric oxide also plays a central role in the (patho)physiology
of the airways, highlighted by Maniscalco (13), and bone, reviewed by Pilz (14). Indeed, the
latter review highlights the potential role of regulators of nitric oxide signaling in preventing
and reversing the effects of disorders of bone resorption, for example osteoporosis. Finally,
Girotti (15) reviews the effects of nitric oxide in opposing the activities of photosensitizing
agents, through redox mechanisms, which are the key to photodynamic therapy for a number
of tumor types. This review underscores the potential utility of inhibitors of nitric oxide
production in potentiating the anti-tumor effects of photodynamic therapy.
Spoon feeding in the long run teaches us nothing but the shape of the spoon
E.M. Forrester
Beyond the science, Dr. Murad has been the consummate mentor. He has trained scores of
fellows, physician scientists, and doctoral students and many have gone on to leadership

positions in academia and the biopharmaceutical sector internationally. One of us (SAW) spent
8 years as a trainee with him and it is a rare opportunity for a former fellow to pay tribute to a
mentor who continues to be an inspiration and key advisor professionally and personally. I first
arrived in Dr. Murad’s laboratory in 1979 as a relatively inexperienced newly minted PhD who
trained in a small laboratory. Immersion into the Murad laboratory was culture shock because
it was extremely large, internationally diverse, and brought together the talents and skills of
many specialties and disciplines. My entry into this world was right at the time when the
studies of nitrovasodilators, nitric oxide, and soluble guanylyl cyclase were the central focus of
the laboratory. Instinctively, Ferid new exactly what was required to evolve a fellow into an
independent scientist. As trainees, he insisted that we take ownership of, and responsibility
for, our projects. He was masterful in formulating hypotheses, and he was astonishingly good
at troubleshooting experiments. However, he made it a priority to have us troubleshoot our
own experiments, and formulate our own biological hypotheses for testing. His philosophy was
that if he spoon fed us, we would never learn to stand up on our own two legs. This “tough
love” was effective, the years I spent with him somehow rubbed off, and now I take the same
approach with my own trainees. Beyond these professional skills, Ferid taught me that the only
questions worth chasing are the big ones that can shift the mechanistic paradigm, and that
have the ability to impact therapeutic strategies and disease management paradigms for
devastating illnesses. Ultimately, I internalized his lessons and have pursued an independent
career in translational pharmacology in the area of cancer. I still depend on those lessons, and I
still get together with my old mentor to discuss strategies to navigate the complexities of the
professional, and personal, world. What began as a mentor-mentee relationship ultimately
evolved into a lifelong friendship that I will always cherish.
So Dr. Murad, happy 80th birthday from your friends and colleagues, students and fellows, and
all the beneficiaries of your seminal discoveries. You have created a legacy in science and
medicine which are prodigious and extraordinary. Importantly, beyond what you have
discovered, there are scores of us who are standing on your shoulders trying to get a glimpse of
the next scientific horizons. We thank you for those broad shoulders and your support.

